Zota Healthcare P/E Ratio
Zota Healthcare (ZOTA) P/E ratio is not applicable — EPS (TTM) ₹-22.46, 8 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 8 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 8
Current EPS: ₹-22.46
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -4.13 | -15 | Loss |
| Sept 2025 | -5.26 | -16 | Loss |
| Mar 2025 | -4.57 | -13 | Loss |
| Jun 2025 | -4.92 | -14 | Loss |
| Dec 2025 | -9.44 | -30 | Loss |
| Sept 2024 | -4.57 | -12 | Loss |
| Mar 2024 | -2.68 | -7 | Loss |
| Jun 2024 | -4.80 | -13 | Loss |
Healthcare Peers with Valid P/E Ratios — ZOTA Comparison
Healthcare sector average P/E 54.8, median 31.04 — ZOTA excluded (negative EPS).
Sector Average PE
54.8
Sector Median PE
31.04
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.89 | ₹69 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see ZOTA stock price BSE.
- Read ZOTA dividend payout details for the complete payout history and dividend yield track record.
- See ZOTA book value to compare market price against book value per share.